Pure Global AI
CDSCO UID MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765

Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing

TULIP DIAGNOSTICS PRIVATE LIMITEDDevice Class Class DIndia CDSCOBrand: RPR
VerifiedCDSCO · official registry
Registration details
UID
MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765
Device class
Class D
Brand name
RPR
License holder
TULIP DIAGNOSTICS PRIVATE LIMITED
Approving authority
Sub Zonal Goa
Product information
Eryscreen Plus is a reagent combipack for ABO grouping, Rho (RPR) typing and confirmation by slide or tube test and is 100% specific to A1, A2, Ax, B, negative reacting with Acquired B characteristics, A & B antigen and Rho(RPR) antigens
About this record

Anti-A, Anti-B, Anti-D IgM+IgG Reagent Combipack for Routine Blood Grouping and Typing is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_e796e28090c4e156ff01419c240e8dbc_25a109280f502ac96adedf402c283765. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.